Latest Racing News

Fortescue has secured a landmark RMB 14.2 billion syndicated term loan, marking the first such facility by an Australian corporate and underscoring its deepening ties with China to support its decarbonisation goals.

Race Oncology’s Phase 1b/2 trial of RC110 bisantrene for relapsed or refractory acute myeloid leukemia has demonstrated a 40% response rate, exceeding expectations and offering new hope for difficult-to-treat patients.

Nimy Resources has identified a significant copper-zinc-gold anomaly at its Sneaky Squirrel Gossan Prospect within the Mons Project, Western Australia, hinting at a potential volcanogenic massive sulphide deposit similar to Golden Grove.

Robex Resources has successfully listed on the ASX, raising A$120 million to fund its Kiniéro Gold Project in Guinea, which remains on track for first gold production in late 2025. Meanwhile, steady output continues at its Nampala Mine in Mali despite rising costs.

Top End Energy has made significant strides in its Serpentine Natural Hydrogen Project in Kansas, expanding its leasehold and initiating a farm-out process amid growing industry interest. Meanwhile, exploration continues in Australia’s Beetaloo Basin as the company prepares for a U.S. investor push through an upcoming ADR listing.

Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.

Firebird Metals is developing Lithium Manganese Rich cathode materials to target next-generation solid-state batteries, aiming to strengthen its position in the evolving EV and high-energy battery markets.

Avecho Biotechnology has ramped up recruitment in its pivotal Phase III insomnia trial and is advancing plans for regulatory approval and commercialization of its TPM®-enhanced CBD capsule, aiming to be the first over-the-counter CBD insomnia treatment in Australia.

Resolution Minerals Limited is set to pursue a dual-listing on the NASDAQ in Q4 2025, aiming to tap into deeper U.S. capital markets and enhance its profile among American investors. The move supports the development of its critical minerals Horse Heaven project in Idaho, aligning with U.S. national security interests.

Canyon Resources has achieved critical milestones for its Minim Martap Bauxite Project, including port access approval and a substantial credit facility, setting the stage for production and first shipment in early 2026.

Anatara Lifesciences has received nearly $1 million from the Australian Government’s R&D tax incentive, providing a vital capital injection to advance its Anti-Obesity pre-clinical studies.

Ionic Rare Earths’ Brazilian joint venture, Viridion, has advanced to the next phase of securing a substantial US$900 million funding package from Brazilian government agencies to develop rare earth refining and recycling facilities.